- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2650EUR$2,750USD£2,279GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2650EUR$2,750USD£2,279GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2650EUR$2,750USD£2,279GBP
- Report
- January 2022
- 200 Pages
Global
From €7227EUR$7,500USD£6,217GBP
- Report
- January 2022
- 200 Pages
Global
From €7227EUR$7,500USD£6,217GBP
- Report
- January 2022
- 60 Pages
Global
From €3806EUR$3,950USD£3,274GBP
- Report
- January 2022
- 60 Pages
Global
From €3806EUR$3,950USD£3,274GBP
- Report
- January 2022
- 60 Pages
Global
From €3806EUR$3,950USD£3,274GBP
- Report
- January 2022
- 200 Pages
Global
From €7227EUR$7,500USD£6,217GBP
- Report
- January 2022
- 60 Pages
Global
From €3806EUR$3,950USD£3,274GBP
- Report
- August 2022
- 115 Pages
Global
From €4336EUR$4,500USD£3,730GBP
- Report
- April 2023
- 162 Pages
Global
From €2409EUR$2,500USD£2,072GBP
- Report
- August 2022
United States
From €1869EUR$1,940USD£1,608GBP
- Report
- August 2022
Global
From €1050EUR$1,090USD£903GBP
- Report
- August 2021
Global
From €3845EUR$3,990USD£3,307GBP
- Report
- August 2021
Europe
From €3295EUR$3,420USD£2,835GBP
- Report
- February 2021
Global
From €2852EUR$2,960USD£2,453GBP
- Report
- November 2022
- 107 Pages
Global
From €3806EUR$3,950USD£3,274GBP
- Report
- February 2022
- 26 Pages
Global
From €3850EUR$3,995USD£3,311GBP
- Report
- November 2018
- 30 Pages
Global
From €3850EUR$3,995USD£3,311GBP
The Eczema Drug market is a subset of the Dermatological Drugs market, which includes medications used to treat skin conditions. Eczema drugs are used to treat the symptoms of eczema, a chronic skin condition characterized by red, itchy, and inflamed skin. These drugs are typically topical creams, ointments, and lotions, and may contain corticosteroids, calcineurin inhibitors, and other active ingredients. In addition to treating the symptoms of eczema, these drugs may also help to reduce the risk of infection and improve the overall quality of life for those affected by the condition.
Some companies in the Eczema Drug market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Mylan. Show Less Read more